Drug Inspector as an antibiotic steward: challenges and recommendations to implement national action plan of Pakistan on antimicrobial resistance

被引:1
作者
Bajwa, Mishal [1 ]
Afzal, Shairyar [2 ,3 ]
Sheikh, Sadaf Areej [4 ]
Saleem, Zikria [5 ]
机构
[1] Quaid i Azam Univ, Dept Pharm, Islamabad, Pakistan
[2] Hamdard Univ, Fac Pharm, Dept Pharm Practice, Islamabad Campus, Islamabad, Pakistan
[3] DHQ Hosp Jhelum, Dept Pharm, Jhelum, Pakistan
[4] Univ Vet & Anim Sci, Dept Pharmacol & Toxicol, Lahore, Punjab, Pakistan
[5] Bahauddin Zakariya Univ, Fac Pharm, Dept Pharm Practice, Multan, Punjab, Pakistan
关键词
Antimicrobial resistance (AMR); antibiotic steward; antibiotic use surveillance; drug inspector (DI); national action plan (NAP); non-prescription sale; rational utilization; POLICY;
D O I
10.1080/14787210.2024.2368825
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
BackgroundDespite significant measures, low- and middle-income countries (LMICs), including Pakistan, struggle to curtail non-prescription antibiotic sales, enforce regulations, and implement National Action Plan (NAP) against antimicrobial resistance (AMR). NAP Pakistan entails drug inspectors (DIs) to ensure prescription-based sales of antibiotics. This study seeks to understand the perspective of DIs regarding antimicrobial sales without prescription, underlying factors, and policy implementation status.MethodsA qualitative study employing a semi-structured interview guide using in-depth interviews with purposively selected 17 DIs was conducted. Interviews were transcribed verbatim, and data were analyzed following a thematic analysis framework utilizing MAXQDA 2022 software.ResultsFive main themes emerged after data analysis: (1) drug inspector - the regulator of the antimicrobial armamentarium, (2) the policy context, (3) awareness regarding AMR, (4) barriers to combatting AMR, and (5) the way forward: strategies and recommendations.ConclusionA weak regulatory framework, low level of awareness, quackery, vested interests, and socio-economic factors augment inappropriate antibiotic utilization. Opting for better policies and strengthening the DI fraternity as outlined in NAP Pakistan is recommended. Recognizing drug inspectors as effective surveilling units and mobilizing field force against irrational antibiotic utilization is the need of the hour and requires policy reformation.
引用
收藏
页码:907 / 920
页数:14
相关论文
共 46 条
  • [1] Research and scholarly methods: Semi-structured interviews
    Adeoye-Olatunde, Omolola A.
    Olenik, Nicole L.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2021, 4 (10): : 1358 - 1367
  • [2] Antibiotic resistance in Pakistan: a systematic review of past decade
    Bilal, Hazrat
    Khan, Muhammad Nadeem
    Rehman, Tayyab
    Hameed, Muhammad Fazal
    Yang, Xingyuan
    [J]. BMC INFECTIOUS DISEASES, 2021, 21 (01)
  • [3] One size fits all? What counts as quality practice in (reflexive) thematic analysis?
    Braun, Virginia
    Clarke, Victoria
    [J]. QUALITATIVE RESEARCH IN PSYCHOLOGY, 2021, 18 (03) : 328 - 352
  • [4] Byrne D., 2022, Quality Quantity, V56, P1391, DOI [DOI 10.1007/S11135-021-01182-Y, 10.1007/s11135-021-01182-y, 10.1177/1609406917733847]
  • [5] An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations
    Charani, Esmita
    Mendelson, Marc
    Pallett, Scott J. C.
    Ahmad, Raheelah
    Mpundu, Mirfin
    Mbamalu, Oluchi
    Bonaconsa, Candice
    Nampoothiri, Vrinda
    Singh, Sanjeev
    Peiffer-Smadja, Nathan
    Anton-Vazquez, Vanesa
    Moore, Luke S. P.
    Schouten, Jeroen
    Kostyanev, Tomislav
    Vlahovic-Palcevski, Vera
    Kofteridis, Diamantis
    Correa, Juliana Silva
    Holmes, Alison H.
    [J]. LANCET GLOBAL HEALTH, 2023, 11 (03): : E456 - E464
  • [6] Exploring the evidence base for national and regional policy interventions to combat resistance
    Dar, Osman A.
    Hasan, Rumina
    Schlundt, Jorgen
    Harbarth, Stephan
    Caleo, Grazia
    Dar, Fazal K.
    Littmann, Jasper
    Rweyemamu, Mark
    Buckley, Emmeline J.
    Shahid, Mohammed
    Kock, Richard
    Li, Henry Lishi
    Giha, Haydar
    Khan, Mishal
    So, Anthony D.
    Bindayna, Khalid M.
    Kessel, Anthony
    Pedersen, Hanne Bak
    Permanand, Govin
    Zumla, Alimuddin
    Rottingen, John-Arne
    Heymann, David L.
    [J]. LANCET, 2016, 387 (10015) : 285 - 295
  • [7] The Ethics of Pharma-Physician Relations in Pakistan: "When in Rome"
    de Andrade, Marisa
    Jafarey, Aamir
    Shekhani, Sualeha Siddiq
    Angelova, Nikolina
    [J]. ETHICS & BEHAVIOR, 2019, 29 (06) : 473 - 489
  • [8] Public knowledge and behaviours concerning antibiotic use and resistance in France: a cross-sectional survey
    Demore, Beatrice
    Mangin, Lucie
    Tebano, Gianpiero
    Pulcini, Celine
    Thilly, Nathalie
    [J]. INFECTION, 2017, 45 (04) : 513 - 520
  • [9] DRAP, 2023, DRUG REGULATORY AUTH
  • [10] The General Population's Inappropriate Behaviors and Misunderstanding of Antibiotic Use in China: A Systematic Review and Meta-Analysis
    Duan, Lixia
    Liu, Chenxi
    Wang, Dan
    [J]. ANTIBIOTICS-BASEL, 2021, 10 (05):